Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Randall Hlubek

Neurological Surgery Cincinnati, OH Medical Doctor

NPI 1992069652 CMS profile 271760

3825 Edwards Rd Ste 300, Cincinnati, OH 45209

Open in the dashboard

General payments

$40,629

103 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Randall Hlubek of Cincinnati, OH is reported in the CMS Open Payments database as having received $40,629 across 103 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 84th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $199 3
2024 General $7,777 5
2023 General $15,187 26
2022 General $15,363 27
2021 General $582 12
2020 General $553 11
2019 General $966 19

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Randall Hlubek
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Randall Hlubek were reported at $199. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Randall Hlubek Neurological Surgery median Middle half National median
2019 $966 $582 $138–$3,006 $163
2020 $553 $294 $76–$2,174 $114
2021 $582 $387 $105–$2,432 $132
2022 $15,363 $542 $139–$2,989 $149
2023 $15,187 $534 $145–$2,697 $160
2024 $7,777 $574 $155–$3,046 $164
2025 $199 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Alphatec Spine, Inc $38,183 51 payments
  2. NuVasive, Inc. $1,975 43 payments
  3. Medtronic, Inc. $170 1 payment
  4. Medtronic USA, Inc. $111 1 payment
  5. Boston Scientific Corporation $82 3 payments
  6. Globus Medical, Inc. $62 2 payments
  7. Zimvie Inc. $24 1 payment
  8. SI-BONE, Inc. $20 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $22,938 4 payments
  2. Travel and Lodging $12,566 21 payments
  3. Food and Beverage $5,125 78 payments
Products named General payments · program years 2019–2025
  1. Other - Miscellaneous $18,121 21 payments
  2. IdentiTi $10,480 4 payments
  3. Solus ALIF $6,913 3 payments
  4. Battalion LLIF $6,500 1 payment
  5. LIF $497 7 payments
  6. Pulse Spine/Spine Surgery $342 6 payments
  7. Pulse Spine/Spine Surgery $279 7 payments
  8. Osteocel $253 4 payments
  9. XLIF $252 7 payments
  10. Battalion TLIF - PC $179 1 payment
  11. Other $1,538 36 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

217

Median for Neurosurgery: 83

Drug cost

$1,880

Median for Neurosurgery: $872

Branded share of claims

17.5%

Median for Neurosurgery: 16.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 81 $734
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 38 $417
Methocarbamol Generic 43 $326
Oxycodone Hcl Generic 23 $163
Cyclobenzaprine Hcl Generic 12 $125
Methylprednisolone Generic 20 $115

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 51 billing codes

Paid by Medicare

$284,215

Medicare's payments for the services billed

Medicare patients

338

Average age 73

Services billed

1,802

174 women, 164 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Depression 33%
Ischemic heart disease 28%
Diabetes 24%
Chronic kidney disease 24%
Atrial fibrillation 20%
Osteoporosis 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

103 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record